These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25519966)

  • 1. [Neurodegenerative disease and TREM2].
    Takahashi K
    Rinsho Shinkeigaku; 2014; 54(12):1122-4. PubMed ID: 25519966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM2 sustains microglial expansion during aging and response to demyelination.
    Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M
    J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.
    Neumann H; Takahashi K
    J Neuroimmunol; 2007 Mar; 184(1-2):92-9. PubMed ID: 17239445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular Pathogenesis of Nasu-Hakola Disease Brain Lesions].
    Satoh J
    Brain Nerve; 2016 May; 68(5):543-50. PubMed ID: 27156507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 in CNS homeostasis and neurodegenerative disease.
    Painter MM; Atagi Y; Liu CC; Rademakers R; Xu H; Fryer JD; Bu G
    Mol Neurodegener; 2015 Sep; 10():43. PubMed ID: 26337043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.
    Varnum MM; Clayton KA; Yoshii-Kitahara A; Yonemoto G; Koro L; Ikezu S; Ikezu T
    J Biol Chem; 2017 Jun; 292(25):10651-10663. PubMed ID: 28490631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-Associated Mutations of TREM2 Alter the Processing of N-Linked Oligosaccharides in the Golgi Apparatus.
    Park JS; Ji IJ; An HJ; Kang MJ; Kang SW; Kim DH; Yoon SY
    Traffic; 2015 May; 16(5):510-8. PubMed ID: 25615530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic insights into the deleterious roles of Nasu-Hakola disease associated TREM2 variants.
    Dash R; Choi HJ; Moon IS
    Sci Rep; 2020 Feb; 10(1):3663. PubMed ID: 32107424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.
    Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM
    Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.
    Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Arima K
    Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous TREM2 c.549del; p.(Leu184Serfs*5) variant causing Nasu-Hakola disease in three siblings in a consanguineous Iraqi family: Case report and review of literature.
    Gilani N; Bitarafan F; Ozaslan M; Åsheim S; Heidari M; Garshasbi M
    Mol Genet Genomic Med; 2024 Jun; 12(6):e2476. PubMed ID: 38888203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
    Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
    Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TREM2 Gene Compound Heterozygosity in Neurodegenerative Disorders.
    Berdyński M; Ludwiczak J; Barczak A; Barcikowska-Kotowicz M; Kuźma-Kozakiewicz M; Dunin-Horkawicz S; Żekanowski C; Borzemska B
    J Alzheimers Dis; 2022; 89(4):1211-1219. PubMed ID: 36031890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic insights into the effects of nonsynonymous polymorphisms (nsSNPs) on loss of TREM2 function.
    Dash R; Munni YA; Mitra S; Choi HJ; Jahan SI; Chowdhury A; Jang TJ; Moon IS
    Sci Rep; 2022 Jun; 12(1):9378. PubMed ID: 35672339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM2 Variants and Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
    Zhou SL; Tan CC; Hou XH; Cao XP; Tan L; Yu JT
    J Alzheimers Dis; 2019; 68(3):1171-1184. PubMed ID: 30883352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Triggering Receptor Expressed on Myeloid Cells 2: A Molecular Link of Neuroinflammation and Neurodegenerative Diseases.
    Walter J
    J Biol Chem; 2016 Feb; 291(9):4334-41. PubMed ID: 26694609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer's Disease and Schizophrenia.
    Mori Y; Yoshino Y; Ochi S; Yamazaki K; Kawabe K; Abe M; Kitano T; Ozaki Y; Yoshida T; Numata S; Mori T; Iga J; Kuroda N; Ohmori T; Ueno S
    PLoS One; 2015; 10(9):e0136835. PubMed ID: 26332043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasu-Hakola disease: a rare entity in Italy. Critical review of the literature.
    Montalbetti L; Soragna D; Ratti MT; Bini P; Buscone S; Moglia A
    Funct Neurol; 2004; 19(3):171-9. PubMed ID: 15595711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
    Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
    J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.